The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale

Background: Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory...

Full description

Bibliographic Details
Main Authors: Binita Shah, Lisa Ganguzza, James Slater, Jonathan D. Newman, Nicole Allen, Edward Fisher, John Larigakis, Francisco Ujueta, Eugenia Gianos, Yu Guo, Kathleen Woolf
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Contemporary Clinical Trials Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865417300662
_version_ 1818260055647059968
author Binita Shah
Lisa Ganguzza
James Slater
Jonathan D. Newman
Nicole Allen
Edward Fisher
John Larigakis
Francisco Ujueta
Eugenia Gianos
Yu Guo
Kathleen Woolf
author_facet Binita Shah
Lisa Ganguzza
James Slater
Jonathan D. Newman
Nicole Allen
Edward Fisher
John Larigakis
Francisco Ujueta
Eugenia Gianos
Yu Guo
Kathleen Woolf
author_sort Binita Shah
collection DOAJ
description Background: Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic profiles in patients with angiographically defined coronary artery disease (CAD). Study design: This study is a randomized, open label, blinded end-point trial of 100 patients with CAD as defined by ≥ 50% diameter stenosis in a coronary artery ≥2 mm in diameter on invasive angiography. Participants are randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017). Participants are provided weekly groceries that adhere to the guidelines of their diet. The primary endpoint is high sensitivity C-reactive concentrations. Secondary endpoints include anthropometric data, other markers of inflammation, lipid parameters, glycemic markers, endothelial function, quality of life data, and assessment of physical activity. Endpoints are measured at each visit (baseline, 4 weeks, and 8 weeks). Dietary adherence is measured by two weekly 24-h dietary recalls, a 4-day food record during the week prior to each visit, and both plasma and urine levels of trimethylamine-N-oxide at each visit. Conclusion: This study is the first to comprehensively assess multiple indices of inflammation and glucometabolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-recommended diet.
first_indexed 2024-12-12T18:25:15Z
format Article
id doaj.art-78e8f793087d4710a49a342326d95d4e
institution Directory Open Access Journal
issn 2451-8654
language English
last_indexed 2024-12-12T18:25:15Z
publishDate 2017-12-01
publisher Elsevier
record_format Article
series Contemporary Clinical Trials Communications
spelling doaj.art-78e8f793087d4710a49a342326d95d4e2022-12-22T00:16:02ZengElsevierContemporary Clinical Trials Communications2451-86542017-12-018C909810.1016/j.conctc.2017.09.003The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationaleBinita Shah0Lisa Ganguzza1James Slater2Jonathan D. Newman3Nicole Allen4Edward Fisher5John Larigakis6Francisco Ujueta7Eugenia Gianos8Yu Guo9Kathleen Woolf10Department of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Medicine (Cardiology), New York University (NYU) School of Medicine, New York, NY, USADepartment of Population Health (Biostatistics), NYU School of Medicine, New York, NY, USADepartment of Nutrition and Food Studies, NYU Steinhardt, New York, NY, USABackground: Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic profiles in patients with angiographically defined coronary artery disease (CAD). Study design: This study is a randomized, open label, blinded end-point trial of 100 patients with CAD as defined by ≥ 50% diameter stenosis in a coronary artery ≥2 mm in diameter on invasive angiography. Participants are randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017). Participants are provided weekly groceries that adhere to the guidelines of their diet. The primary endpoint is high sensitivity C-reactive concentrations. Secondary endpoints include anthropometric data, other markers of inflammation, lipid parameters, glycemic markers, endothelial function, quality of life data, and assessment of physical activity. Endpoints are measured at each visit (baseline, 4 weeks, and 8 weeks). Dietary adherence is measured by two weekly 24-h dietary recalls, a 4-day food record during the week prior to each visit, and both plasma and urine levels of trimethylamine-N-oxide at each visit. Conclusion: This study is the first to comprehensively assess multiple indices of inflammation and glucometabolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-recommended diet.http://www.sciencedirect.com/science/article/pii/S2451865417300662Diet interventionCoronary artery diseaseInflammationGlucoseLipids
spellingShingle Binita Shah
Lisa Ganguzza
James Slater
Jonathan D. Newman
Nicole Allen
Edward Fisher
John Larigakis
Francisco Ujueta
Eugenia Gianos
Yu Guo
Kathleen Woolf
The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale
Contemporary Clinical Trials Communications
Diet intervention
Coronary artery disease
Inflammation
Glucose
Lipids
title The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale
title_full The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale
title_fullStr The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale
title_full_unstemmed The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale
title_short The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale
title_sort effect of a vegan versus aha diet in coronary artery disease evade cad trial study design and rationale
topic Diet intervention
Coronary artery disease
Inflammation
Glucose
Lipids
url http://www.sciencedirect.com/science/article/pii/S2451865417300662
work_keys_str_mv AT binitashah theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT lisaganguzza theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT jamesslater theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT jonathandnewman theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT nicoleallen theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT edwardfisher theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT johnlarigakis theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT franciscoujueta theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT eugeniagianos theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT yuguo theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT kathleenwoolf theeffectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT binitashah effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT lisaganguzza effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT jamesslater effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT jonathandnewman effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT nicoleallen effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT edwardfisher effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT johnlarigakis effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT franciscoujueta effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT eugeniagianos effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT yuguo effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale
AT kathleenwoolf effectofaveganversusahadietincoronaryarterydiseaseevadecadtrialstudydesignandrationale